With shares of Citigroup (NYSE:C) trading around $48, is C an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementCitigroup is a global diversified financial services holding company providing consumers, corporations, governments, and institutions with a broad range of financial products and services. It operates in two segments: Citicorp and Citi Holdings. The company�� products and services are: consumer banking and credit, corporate and investment banking, securities brokerage, wealth management, and transaction services to consumers, corporations, governments, and institutions worldwide.
Citigroup said on Friday that it discovered fraudulent loans in its Mexico subsidiary and that its employees may have been in on the crime.�Writing down the loans will reduce the bank’s 2013 net income by $235 million, bringing the previously reported total to $13.91 billion, the bank said in a statement.�Citigroup said it believes at this point that the incident was an isolated episode. The bad loans were made to Oceanografia SA de CV, a Mexican oil services company that is a contractor for the nation’s state-owned oil company, Pemex. Oceanografia is in the middle of a corruption probe in Mexico.�Oceanografia borrowed from Citigroup’s Mexican unit, Banco Nacional de Mexico or Banamex, using expected payments from Pemex as collateral.�Banamex discovered in a recent review that Oceanografia appeared to have falsified invoices to Pemex that were collateral for loans, Citigroup Chief Executive Michael Corbat said in a separate memo to employees. The bank wrote down about $400 million of loans backed by the bogus invoices.
Top Oil Service Stocks To Watch Right Now: THERMOGENESIS Corp.(KOOL)
ThermoGenesis Corp. designs, develops, and sells medical products that enable the practice of regenerative medicine worldwide. It offers automated and semi-automated devices, and single-use processing disposables that enable the collection, processing, and cryopreservation of stem cells and other cellular tissues used in the practice of regenerative medicine. Regenerative medicine is a field that uses cell-based therapies to repair or restore lost or damaged tissue and cell function. The company?s products include the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; Res-Q 60 BMC, a point-of-care bone marrow stem cell processing system; and Res-Q 60 PRP, which is used for t he preparation of autologous platelet rich plasma from a sample of blood at the point of care. It also offers ThermoLine product line, which includes ultra-rapid plasma ThermoLine Freezer and ultra-rapid plasma ThermoLine Thawer; and CryoSeal System, an automated system, which is used to prepare an autologous hemostatic surgical sealant. ThermoGenesis Corp. was founded in 1986 and is based in Rancho Cordova, California.
Advisors' Opinion:- [By John Udovich]
The controversy over stem cell research or their usage seems to have ebbed in recent years as stem cell science moves beyond the use of embryos and lately there has been a steady flow of overlooked good news from the sector or from small cap stem cell stocks like Cellular Dynamics (which will IPO soon), ThermoGenesis Corp (NASDAQ: KOOL) and BioRestorative Therapies (OTCBB: BRTX) for investors to digest. Just consider the following news:
- [By Monica Gerson]
ThermoGenesis (NASDAQ: KOOL) moved up 29.81% to $2.9857. ThermoGenesis' trailing-twelve-month revenue is $17.49 million.
Infosonics (NASDAQ: IFON) shares jumped 22.64% to $2.06. Infosonics shares have jumped 170.97% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
Top Oil Service Stocks To Watch Right Now: The NASDAQ OMX Group Inc.(NDAQ)
The NASDAQ OMX Group, Inc. provides trading, clearing, exchange technology, securities listing, and public company services worldwide. It offers trading across various asset classes, including cash equities, derivatives, debt, commodities, structured products, and exchange traded funds; capital formation solutions; financial services and exchanges technology; market data products; and financial indexes, as well as clearing, settlement, and depository services. The company also provides broker services comprising technology and customized securities administration solutions, such as back-office systems to financial participants. In addition, it offers global listing services; technology solutions for trading, clearing, settlement, and information dissemination; and facility management integration, surveillance solutions, and advisory services, as well as develops and licenses NASDAQ OMX branded indexes, associated derivatives, and financial products. As of December 31, 2010 , a total of 2,778 companies listed securities on The NASDAQ Stock Market. The NASDAQ OMX Group supports the operations of approximately 70 exchanges, clearing organizations, and central securities depositories. The company was formerly known as The Nasdaq Stock Market, Inc. and changed its name to The NASDAQ OMX Group, Inc. in February 2008. The NASDAQ OMX Group, Inc. was founded in 1971 and is based in New York, New York.
Advisors' Opinion:- [By Dave Michaels]
Midas provides the regulator with more complete data than traders and researchers can see from the public price feeds operated by NYSE Euronext (NYX) and Nasdaq OMX Group Inc. (NDAQ) Midas includes every order on exchanges, not just the best offers reported to the public tape. It also gathers data on orders that are modified, canceled or filled.
- [By Maureen Farrell]
Twitter will try not to mimic Facebook's mistakes on IPO day.
NEW YORK (CNNMoney) At the start of last year, Nasdaq (NDAQ) and Morgan Stanley (MS, Fortune 500) were on top of the tech world. Both landed key roles in Facebook's hotly anticipated initial public offering.But Facebook's IPO changed that. Both companies were widely criticized for Facebook's face plant of a debut. The problems that marred Facebook's IPO clearly hurt the image of Nasdaq and Morgan Stanley.
Top Defensive Companies To Own In Right Now: AKB Mosoblbank OAO (MOBB)
AKB MOSOBLBANK OAO (AKB MOSOBLBANK OJSC) is a Russia-based commercial bank. The Company focuses on the provision of various types of banking services to both individual and corporate clients. The Bank offers its services through the network of 400 offices and automated teller machines (ATM), located across the Russian Federation. In addition, it has 23 branches in such cities as: Rostov na Donu, Samara, Astrakhan, Arkhangelsk, Nizhny Novgorod, Omsk, Tyumen, Yakutsk, Grozny, Kemerovo and Vladivostok, among others. As of May 25, 2012, the Company�� major shareholder was Respublikanskaya Finansovaya Korporatsiya OAO with a stake of 74.19%. Advisors' Opinion:- [By Corinne Gretler]
UBS, Switzerland�� largest bank, rallied to a two-year high. Philips, the Dutch maker of light bulbs and electric toothbrushes, gained for an eighth day. Portugal�� PSI-20 Index (PSI20) advanced 2.3 percent as President Anibal Cavaco Silva affirmed that he doesn�� want to call early elections. Mobistar (MOBB) SA slumped the most on record after the Belgian mobile-phone company cut profit forecasts and suspended its dividend.
Top Oil Service Stocks To Watch Right Now: Clovis Oncology Inc (CLVS)
Clovis Oncology, Inc. (Clovis) incorporated on April 20, 2009, is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer populations. During the year ended December 31, 2010, the Company was in the process of developing three product candidates for which it holds global marketing rights: CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine; CO-1686, an oral epidermal growth factor receptor (EGFR) mutant-selective inhibitor and CO-338, a poly ADP (Adenosine Diphosphate)-ribose polymerase (PARP) inhibitor. Effective November 19, 2013, Clovis Oncology Inc acquired the entire share capital of Ethical Oncology Science SpA.
CO-101 - a Lipid-Conjugated Form of the Anti-Cancer Drug Gemcitabine
CO-101 is designed to treat patients with pancreatic cancer whose tumors express low amounts of a membrane transporter protein on the surface of the cancer cell known as hENT1 and are thus expected to be resistant to standard gemcitabine-based therapy. Based on the published results of multiple studies assessing the correlation of hENT1 expression to survival outcomes in pancreatic cancer patients treated with gemcitabine, the Company estimates that approximately 40% to 50% of pancreatic patients express low levels of hENT1, and thus derive little or no benefit from gemcitabine therapy. CO-101 is in an international, randomized and controlled 360-patient study for the first-line treatment of metastatic pancreatic cancer. This open-label study compares CO-101 to gemcitabine as a first-line therapy in patients with metastatic pancreatic cancer. Clovis is partnered with Ventana Medical Systems for the development and commercialization of a companion diagnostic for the assessment of hENT1 levels.
CO-1686-an Oral EGFR Mutant-Selective ! Inhibitor
CO-1686 is an orally available, small molecule covalent inhibitor of the cancer-causing mutant forms of EGFR for the treatment of non-small cell lung cancer (NSCLC). CO-1686 targets both the initial activating EGFR mutations as well as the primary resistance mutation, T790M, it treats both first- and second-line NSCLC patients with EGFR mutations. Such initiating activating mutations occur in approximately 10% to 15% of NSCLC cases in Caucasian patients and approximately 30% to 35% of NSCLC cases in East Asian patients. Following treatment with approved NSCLC therapies, Tarceva (erlotinib) or Iressa (gefitinib), both known as tyrosine kinase inhibitors (TKIs), approximately half of these patients develop the T790M mutation.
The Company focuses on the development of CO-1686 as both a second-line therapy for EGFR-mutated NSCLC patients who become resistant to TKIs due to the emergence of the T790M secondary mutation and as a first-line treatment for EGFR-mutated NSCLC. Clovis is partnered with Roche Molecular Systems for the development and commercialization of a companion diagnostic for identification of EGFR mutations.
CO-338-a PARP Inhibitor
CO-338 is a small molecule PARP inhibitor that the Company focuses to develop as both monotherapy and in combination with chemotherapeutic agents for the treatment of selected cancer patients. CO-338 is in a Phase I clinical trial to determine the maximum tolerated dose of oral CO-338 that can be combined with intravenous, or IV, platinum chemotherapy in the treatment of solid tumors. This program is supplemented by two ongoing investigator-initiated trials, using the IV formulation of CO-338: a Phase I/II study in germ-line BRCA mutant breast and ovarian cancer and a Phase II study in the adjuvant treatment of germ-line BRCA mutant and triple-negative breast cancer. The Company also focuses on initiating a Phase I monotherapy study of the oral formulation, to determine an appropriate dose and schedule.!
The Company competes with Eli Lilly, Teva Pharmaceutical Industries, APP Pharmaceuticals, AB Science SA, Amgen Inc., Astellas Pharma, BioSante Pharmaceuticals, Inc., Celgene Corporation, Immunomedics, Inc., Lorus Therapeutics, Threshold Pharmaceuticals, Inc., Boehringer Ingelheim, Pfizer, Sanofi-Aventis, Astra Zeneca, Abbott, Merck, Eisai, Cephalon and Biomarin.
Advisors' Opinion:- [By Keith Speights]
Give me a double
The Motley Fool's David Williamson summed up the great week for Clovis Oncology (NASDAQ: CLVS ) perfectly in his headline a few days ago: "1 Biotech + 2 Cancer Drugs = 100% Pop." While that 100% pop drifted down to 96% by the end of the week, Dave hit the nail on the head. - [By Brian Orelli]
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology (NASDAQ: CLVS ) looks like the clear winner, more than doubling today as the company presented data on its two cancer drugs rucaparib and CO-1686.
- [By Jake L'Ecuyer]
Clovis Oncology (NASDAQ: CLVS) was also up, gaining 7.26 percent to $79.35 after the company announced 2014 objectives and financial outlook. The company projected to initiate three global registration studies for CO-1686.
- [By Lauren Pollock]
Biotech company Clovis Oncology Inc.(CLVS), which was considering a sale, didn’t enter any deal talks and is no longer seeking bids, Bloomberg News reported, citing a person with knowledge of the matter. Shares dropped 14% to $63.51 premarket.
Top Oil Service Stocks To Watch Right Now: Vectren Corporation (VVC)
Vectren Corporation, through its subsidiaries, provides energy delivery services to residential, commercial, and industrial and other contract customers in Indiana and west central Ohio. It offers natural gas distribution and transportation services, and electric distribution services; and owns and operates coal-fired and gas-fired electric generating facilities with an installed generating capacity of 1,298 megawatts. The company�s electric transmission system consists of 989 circuit miles of 345, 138, and 69 kilovolt lines, and 35 substations; and distribution system comprises 4,281 pole miles of lower voltage overhead lines and 372 trench miles of conduit containing 1,999 miles of underground distribution cable, 96 distribution substations, and 54,000 distribution transformers. In addition, it provides gas marketing, gas portfolio optimization, and other portfolio and energy management services to municipalities, utilities, industrial operations, schools, and healthcar e institutions; mines and sells coal; offers underground construction and repair, performance contracting, and renewable energy services; and invests in energy-related opportunities and services, real estate, and leveraged leases. Further, the company engages in transmission pipeline construction and maintenance; pump station, compressor station, terminal, and refinery construction; and hydrostatic testing services. It serves the automotive assembly, parts, and accessories; feed, flour, and grain processing; metal castings; aluminum products; polycarbonate resin and plastic products; gypsum products; electrical equipment; metal specialties; glass; steel finishing; pharmaceutical and nutritional products; gasoline and oil products; ethanol; and coal mining industries. As of December 31, 2011, it supplied natural gas services to approximately 993,300 customers; and electric services to approximately 141,600 customers. Vectren Corporation was founded in 1912 and is headquartere d in Evansville, Indiana.
Advisors' Opinion:- [By Lawrence Meyers]
I like the diversification, and the fact that the company has offered many of these products for anywhere from 30 years to 100 years may explain why it�� paid a dividend for the last 32 years. That dividend is presently at 4.3%.
Vectren Corporation (VVC)The final stock on our list of secret dividend stocks is Vectren Corporation (VVC). VVC is another an energy play that�� diversified into four segments. The company provides 566,000 customers with natural gas delivery in Indiana.
Top Oil Service Stocks To Watch Right Now: Dorman Products Inc.(DORM)
Dorman Products, Inc. supplies automotive replacement parts, fasteners, and service line products primarily for the automotive aftermarket. The company offers approximately 128,000 products comprising original equipment dealer parts, which include intake manifolds, exhaust manifolds, oil cooler lines, window regulators, radiator fan assemblies, power steering pulleys, and harmonic balancers; and replacement parts, such as window handles and switches, door hardware, interior trim parts, headlamp aiming screws and retainer rings, radiator parts, battery hold-down bolts and repair kits, valve train parts, and power steering filler caps. It also provides application specific and general automotive hardware, such as body hardware, general automotive fasteners, oil drain plugs, and wheel hardware; a selection of electrical connectors, wires, tools, testers, and accessories; and a line of home hardware and home organization products designed for retail merchandisers. In addition, the company offers a brake and clutch program; remanufactured automotive replacement parts, such as transfer case modules and instrument clusters; and heavy duty aftermarket parts for class 4-8 heavy vehicles, including coolant tubes, door handles and other body parts, fluid reservoirs, headlights and lighting, hood components, window regulators, and wiper transmissions. It sells its products under the OE Solutions, HELP!, AutoGrade, FirstStop, Conduct-Tite!, Pik-A-Nut, and HD Solutions brand names through automotive aftermarket retailers; national, regional, and local warehouse distributors; specialty markets; and salvage yards in the United States, Mexico, Europe, the Middle East, Asia, and Canada. The company, formerly known as R&B, Inc., was founded in 1978 and is headquartered in Colmar, Pennsylvania.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Dorman Products (Nasdaq: DORM ) , whose recent revenue and earnings are plotted below.
Top Oil Service Stocks To Watch Right Now: NetSpend Holdings Inc.(NTSP)
Netspend Holdings, Inc., together with its subsidiaries, provides general purpose reloadable (GPR) prepaid debit and payroll cards, and alternative financial service solutions to underbanked and other consumers in the United States. Its GPR cards offer access to FDIC-insured depository accounts with a menu of pricing and features tailored to underbanked consumers needs; and serves as access devices to an FDIC-insured depository account with a bank. The company also provides various products and services to its cardholders, such as direct deposit, interest-bearing savings accounts, bill pay functionality, card-to-card transfer capability, personal financial management tools, and online and mobile phone card account access, as well as overdraft protection through its issuing Banks, and complimentary insurance coverage services. Netspend Holdings, Inc. markets its cards through various distribution channels, including retail distributors, direct-to-consumer and online marketi ng programs, and contractual relationships with corporate employers. As of December 31, 2011, it offered approximately 2.1 million active cards through approximately 600 retail distributors at approximately 40,000 locations; and reload services through approximately 450 retailers at approximately 130,000 locations. The company was founded in 1999 and is based in Austin, Texas.
Advisors' Opinion:- [By Jane Edmondson]
One additional item of note: the stock has been a rumored take-out candidate since another large competitor, NetSpend (NTSP), received an offer to be acquired in February by global payment solutions provider TSYS (TSS).
Top Oil Service Stocks To Watch Right Now: Empire State Realty Trust Inc (ESRT)
Empire State Realty Trust, Inc., incorporated on July 29, 2011, is a self-administered and self-managed real estate investment trust (REIT), which owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area. The Company operates in two segments: real estate and construction contracting. As of June 30, 2013, the Company owned 12 office properties (including one long-term ground leasehold interest) encompassing approximately 7.7 million rentable square feet of office space, which were approximately 83.5% leased (or 86.2% giving effect to leases signed but not yet commenced as of that date). Seven of these properties are located in the midtown Manhattan market and encompass in the aggregate approximately 5.9 million rentable square feet of office space, including the Empire State Building. Its Manhattan office properties also contain an aggregate of 440,615 rentable square feet of retail space on their ground floor and/or lower levels. Its remaining five office properties are located in Fairfield County, Connecticut and Westchester County, New York, encompassing in the aggregate approximately 1.8 million rentable square feet.
The Company has entitled land at the Stamford Transportation Center in Stamford, Connecticut, adjacent to one of its office properties, that supports the development of an approximately 380,000 rentable square foot office building and garage, which refers to herein as Metro Tower. As of June 30, 2013, its portfolio also included four standalone retail properties located in Manhattan and two standalone retail properties located in the city center of Westport, Connecticut, encompassing 204,452 rentable square feet in the aggregate. As of June 30, 2013, its standalone retail properties were 100% leased in the aggregate. In addition, the Company has an option to acquire from affiliates of its predecessor two additional Manhattan office properties encompassing approximately 1.5 million rentable squar! e feet of office space and 153,209 rentable square feet of retail space at the base of the buildings.
The Empire State Building is the Company�� flagship property. The 102-story building consists of 2,701,938 rentable square feet of office space and 167,788 rentable square feet of retail space. The building also includes its observatory and broadcasting operations. The Company�� portfolio includes retail properties located in retail corridors in Manhattan and Westport, Connecticut. Tenants at 10 Union Square in Manhattan include Best Buy Mobile, Starbucks, A&P, Panera Bread, FedEx/Kinko��, Au Bon Pain, Chipotle Mexican Grill, and GameStop. In the greater New York metropolitan area, its portfolio includes high quality suburban office properties in densely populated metropolitan communities in Fairfield County, Connecticut and Westchester County, New York. tenants of the greater New York metropolitan area flagship Metro Center (at the Transportation Center in Stamford, Connecticut) include Thomson Reuters, Jefferies Group, Columbus Circle Investors, Torm Shipping, Olympus Partners, BP Energy, Tweedy, Browne Company and Susquehanna International.
The Company approximately has 242 million square feet of rentable space, which are contained within Midtown�� multi-tenant office buildings. Downtown Chicago and the Washington, D.C. CBD combine has a total of 230 million square feet of office space. Three-quarters 75.3% of Midtown�� office stock is classified as Class A with total square footage of 182 million square feet. The Company approximately has 43.9 million square feet of Midtown office space is counted as Class B stock, accounting for 18.2% of the total market. The remaining 6.5% of Midtown office space (15.8 million square feet) is categorized as Class C space. The Grand Central submarket is a office submarket in Midtown Manhattan with 44 million square feet and is located on the east side of Midtown Manhattan, to the north of Murray Hill and to the south of the Park ! Avenue co! rridor.
The West Side office submarket, located to the south and west of Central Park and including the area around Columbus Circle, consists of 25.8 million square feet of office space. Westchester County contains approximately 28.9 million square feet of office space and is split into six submarkets: White Plains CBD and non-CBD, Northern, Central, Eastern and Southern. The White Plains CBD is situated in south central Westchester County, along the Cross-Westchester Expressway (Interstate 287) corridor between the Sprain Brook Parkway and the Hutchinson River Parkway. The submarket consists of approximately 6.3 million square feet of office space and is defined to include the area south of Barker Avenue, north of Quinby Avenue, east of the Bronx River Parkway and west of South Broadway/Post Road. Westchester�� Eastern office submarket consists of 6.5 million square feet of space and is located to the east of White Plains, between New Rochelle and the Connecticut state border.
Advisors' Opinion:- [By Reuters]
John Moore/Getty Images NEW YORK -- Investors in the Empire State Building have filed a lawsuit accusing the real estate magnates who took it public of short-changing them $300 million by refusing to sell the iconic skyscraper at a premium price. According to a complaint filed Tuesday in a New York state court in Manhattan, Peter Malkin and his son Anthony put their own interests ahead of the building's investors by spurning all-cash offers of as much as $2.3 billion for the building and $1.4 billion for Empire State Building Associates, which held the title and master lease. Instead, the Malkins put the landmark building and 17 other properties into Empire State Realty Trust Inc., whose Oct. 1 IPO valued the property at just $1.89 billion and ESBA at just $1.1 billion, according to the complaint. The lawsuit by plaintiff Marc Postelnek seeks class-action status on behalf of more than 2,800 investors who hold shares in ESBA, which was created in 1961 and was supervised by a Malkin company, Malkin Holdings. It claimed the Malkins acted in bad faith by aborting a "bidding war" for the building, and instead enriched themselves by hundreds of millions of dollars through an IPO. "Given their positions of control and authority over the fate of the Empire State Building, the Malkins had a duty to act in the best interests of their investors," the plaintiffs' lawyer, John Rizio-Hamilton, a partner at Bernstein Litowitz Berger & Grossmann, representing Postelnek, told Reuters. "By failing to properly consider offers to maximize the building's value, the Malkins breached that duty." The lawsuit seeks to recover profit that building investors allegedly lost because of the Malkins' refusal to sell. Empire State Realty Trust, a real estate investment trust, is a successor to Malkin Holdings. "These claims are wholly without merit and we will respond to them in court," a spokeswoman for the REIT said Thursday. ESBA had been created by Lawrence Wien, the father
No comments:
Post a Comment